(NP (NP-COOD (NP (NN Tumor) (NN necrosis) (NN factor) (NN receptor) (NN expression)) (CC and) (NP (NN signal) (NN transduction))) (PP (IN in) (NP (JJ HIV-1-infected) (NNS cells))) (. .))
(S (NP (NN OBJECTIVE) (: :)) (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB examine) (NP (NP (DT the) (NN inter-relationship)) (PP (IN between) (NP-COOD (NP (NN HIV-1) (NN infection)) (CC and) (NP (NP (DT the) (NN cell) (NN surface) (NNS receptors)) (PP (IN for) (NP (NP (NN tumor) (NN necrosis) (NN factor) (-LRB- -LRB-) (NN TNF) (-RRB- -RRB-) (NN -alpha)) (, ,) (NP (NP (DT an) (JJ immunoregulatory) (NN cytokine)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ (-NONE- *T*-1)) (VP (MD can) (VP (VB enhance) (NP (NN HIV-1) (NN replication))))))))))))))) (. .)))
(S (NP (NN DESIGN) (: :)) (S (NP-SBJ-2 (JJ Infected) (ADJP-COOD (ADJP (JJ promyelocytic)) (CC and) (ADJP (JJ promonocytic))) (NNS cells)) (VP (VBD were) (VP (VBN examined) (NP (-NONE- *-2)) (SBAR (IN because) (S (NP-SBJ (PRP they)) (ADVP (RB normally)) (VP (VBP express) (NP (NP (DT both) (NNS types)) (PP (IN of) (NP (NN TNF) (NNS receptors))))))))) (. .)))
(S (NP (NNS METHODS) (: :)) (S-COOD (S (NP-SBJ-3 (NN TNF) (NN receptor) (NN surface) (NN expression)) (VP (VBD was) (VP (VBN determined) (NP (-NONE- *-3)) (PP (IN by) (NP-LGS-COOD (NP (JJ specific) (JJ monoclonal) (NN antibody) (NN recognition)) (CC and) (NP (NN flow) (NN cytometry))))))) (, ,) (CC and) (S (NP-SBJ-4 (NN signal) (NN transduction)) (VP (VBD was) (VP (VBN detected) (NP (-NONE- *-4)) (PP (IN by) (NP-LGS (NN gel) (NN shift) (NN analysis)))))) (. .)))
(S (NP-SBJ-5 (NN HIV-1) (NP-COOD (NP (NN activation)) (CC and) (NP (NN expression)))) (VP (VBD was) (VP (VBN quantitated) (NP (-NONE- *-5)) (PP (IN by) (NP-LGS (JJ reverse) (NN transcriptase) (NN assay))))) (. .))
(S (NP (NNS RESULTS) (: :)) (S (PP (IN In) (NP (NP (DT the) (NN OM-10.1) (JJ promyelocytic) (NN model)) (PP (IN of) (NP (JJ chronic) (NN infection))))) (, ,) (NP-SBJ (JJ TNF-alpha-induced) (NN HIV-1) (NN expression)) (ADVP (RB also)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ substantial) (NN increase)) (PP (IN in) (NP (NP (NP (CD 75) (NN kd) (NN TNF) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TR75)) (-RRB- -RRB-))) (NN expression))))) (SBAR (IN although) (S (NP-SBJ-6 (NP (NP (CD 55) (NN kD) (NN TNF) (NN receptor)) (PRN (-LRB- -LRB-) (NP (NN TR55)) (-RRB- -RRB-))) (NNS levels)) (VP (VBD were) (RB not) (ADVP (RB dramatically)) (VP (VBN altered) (NP (-NONE- *-6))))))) (. .)))
(S (NP-SBJ (NP (DT A) (NN series)) (PP (IN of) (NP (JJ uninfected) (JJ parental) (NN HL-60) (NNS subclones))) (ADVP (DT all))) (VP (VBD reduced) (NP (NN TR75) (NN surface) (NN expression)) (PP (IN in) (NN response) (TO to) (NP (NN TNF-alpha) (NN treatment)))) (. .))
(S (NP-SBJ (NP (VBN Enhanced) (NN TR75) (NN expression)) (PP (IN on) (NP (NN OM-10.1) (NNS cells)))) (VP (VBD followed) (NP (NP (DT the) (JJ same) (NN TNF-alpha-dose) (NN dependency)) (PP (IN as) (NP (NP (WDT that)) (VP (VBN observed) (NP (-NONE- *)) (PP (IN for) (NP (NN HIV-1) (NN production)))))))) (. .))
(S (NP-SBJ (NP (DT An) (NN increase)) (PP (IN in) (NP (NN TR75) (NN expression)))) (VP (VBD was) (ADVP (RB also)) (ADJP-PRD (JJ evident)) (PP-TMP (IN during) (NP (NP (DT the) (NN peak)) (PP (IN of) (NP (NP (DT an) (JJ acute) (NN HIV-1) (NN infection)) (PP (IN of) (NP (NN HL-60) (NNS promyelocytes)))))))) (. .))
(S (SBAR (IN Although) (S (NP-SBJ (NN TR55) (NN expression)) (VP (VBD was) (ADJP-PRD (JJ unaltered)) (PP-TMP (IN during) (NP (JJ TNF-alpha-induced) (NN HIV) (NN activation)))))) (, ,) (NP-SBJ-8 (DT this) (NN receptor)) (VP (VBD was) (ADVP (RB still)) (VP (VBN involved) (NP (-NONE- *-8)) (PP (IN in) (NP (DT the) (JJ viral) (NN activation) (NN process))))) (. .))
(S (NP-SBJ (NP (NN Antibody) (NN cross-linking)) (PP (IN of) (NP (NN TR55)))) (, ,) (PP (IN in) (DT the) (NN absence) (IN of) (NP (JJ exogenous) (NN TNF-alpha))) (, ,) (VP (VBN induced) (NP (NP-COOD (NP (JJ maximal) (NN HIV-1) (NN expression)) (, ,) (NP (NP (DT an) (NN up-modulation)) (PP (IN of) (NP (NN surface) (NN TR75)))) (, ,) (CC and) (NP (JJ nuclear) (NN NF-kappa) (NN B) (NN activity))) (PP (IN in) (NP (NN OM-10.1) (NNS cultures))))) (. .))
(S (ADVP (RB Surprisingly)) (, ,) (NP-SBJ (DT this)) (VP (VBD was) (NP-PRD (DT the) (NN case)) (SBAR-TMP (WHADVP-9 (RB even) (WRB when)) (S (NP-SBJ-10 (DT an) (JJ antagonistic) (JJ anti-TR55) (NN antibody)) (VP (VBD was) (VP (VBN used) (NP (-NONE- *-10)) (ADVP (-NONE- *T*-9))))))) (. .))
(S (NP-SBJ (NP (JJ Anti-TR55) (NN antibody) (NN cross-linking)) (PP (IN in) (NP (ADJP (RB chronically) (JJ infected)) (NN U1) (JJ promonocytic) (NNS cultures)))) (VP (MD could) (ADVP (RB only) (RB partially)) (VP (VB substitute) (PP (IN for) (NP (JJ TNF-alpha-induced) (NN HIV-1) (NN expression))))) (. .))
(S (NP (NNS CONCLUSIONS) (: :)) (S (NP-SBJ (PRP$ Our) (NNS results)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-11 (NN HIV-1) (NN infection)) (VP (MD can) (ADVP (RB selectively)) (VP (VB influence) (NP (NP (DT the) (NN surface) (NN expression)) (PP (IN of) (NP (NN TNF) (NNS receptors)))) (, ,) (S (NP-SBJ (-NONE- *-11)) (ADVP (RB potentially)) (VP-COOD (VP (VBG influencing) (NP (PRP$ its) (JJ own) (NN expression))) (CC and) (VP (VBG altering) (NP (JJ normal) (JJ immunoregulatory) (NN signal) (NN transduction)))))))))) (. .)))
